crenessity
(crinecerfont)Neurocrine Biosciences, Inc.
Usage: CRENESSITY is indicated as adjunctive treatment to glucocorticoid replacement for controlling androgens in adults and pediatric patients aged 4 years and older with classic congenital adrenal hyperplasia (CAH).